期刊文献+

SH-SY5Y神经细胞中尼古丁受体α3亚单位基因表达抑制与APP代谢的关系 被引量:2

Correlation between inhibited gene expression of nicotinic acetylcholine receptor α3 subunit in SH-SY5Y cells and APP metabolism
下载PDF
导出
摘要 目的用RNA干扰技术抑制神经型尼古丁受体(nAChR)α3亚单位基因表达并观察对神经细胞淀粉样蛋白前体蛋白(APP)代谢的影响。方法设计并体外合成α3nAChR的特异性编码siRNA序列的寡核苷酸,退火后克隆至pSliencer3.1-H1neo质粒中,构建重组质粒α3nAChR pSilencer3.1-H1neo。将α3nAChR pSilencer3.1-H1neo转染SH-SY5Y细胞,用含G418的培养液筛选,挑选阳性克隆后采用实时荧光定量PCR和蛋白质印迹方法检测转染细胞中α3nAChR mRNA及蛋白表达水平的变化;并测定分泌型APP、总APP蛋白表达的变化。结果成功构建α3nAChR siRNA表达质粒,转染后经G418筛选获得稳定转染重组质粒的细胞克隆株,与对照组相比,α3nAChR mRNA及蛋白表达量均降低(抑制率分别为98%和66%);分泌型APP表达下降,总APP水平比较表达水平无显著性差异。结论α3nAChR siRNA表达质粒能特异性抑制α3nAChR基因表达,α3nAChR可能通过增加α-分泌酶对APP的切割发挥神经保护作用。 Objective To investigate the influence of inhibited gene expression of α3 nicotinic acetylcholine receptor (nAChR) induced by RNA interference on the metabolism of (-amyloid precursor peptide (APP). Methods The siRNA coding oligonucleotide sequences targeting α3 nAChR were designed and synthesized. The annealed product was cloned into pSliencer 3. 1 -HI neo vector. The recombinant α3 nAChR pSilencer 3. 1-H1 neo vector was transfected into the SH-SYSY cells. The stable clones were screened by G418 medium, and the levels of α3 nAChR mRNA and protein were monitored by using Real-time PCR and Western blotting respectively. The levels of the ( -form of secreted APP ( (APPs) and total APP were also determined by Western blotting. Results Compared with control, the expression levels of mRNA and protein in the SH-SYSY cells transfected with the recombinant α3 nAChR pSilencer 3. 1-HI neo vector were decreased by the inhibitory efficiency with 98% and 66% respectively. The protein level of the αAPPs was reduced and no significant change of total APP was observed. Conclusions The inhibited gene expression of α3 nAChR resulted from the recombinant α3 nAChR siRNA can decrease cleavage of APP by (-secretase, which suggest that α3 nACbR may play a significant neuroprotective role in the pathogenesis of Alzheimer' s disease.
出处 《中国老年学杂志》 CAS CSCD 北大核心 2009年第21期2749-2751,共3页 Chinese Journal of Gerontology
基金 国家自然科学基金资助项目(30870986) 科技部基金资助项目(2006DFA33530) 贵州省科技厅基金项目〔黔科合J字(2007)2092号〕 贵阳医学院院基金(S200703,C2007-10)
关键词 SIRNA α3神经型尼古丁受体 神经母细胞瘤细胞 淀粉样蛋白前体蛋白 Silence interference RNA α3 nAChR Neuroblastoma cell Amyloid precursor peptide
  • 相关文献

参考文献10

  • 1Nordberg A. Nicotinic receptor abnormalities of Alzheimer's disease:therapeutic implications[ J]. Biol Psychiatry,2001 ;49(3 ) :200-10.
  • 2Carson R, Craig D, Mc Guinness B, et al. Alpha7 nicotinic acetylcholine receptor gene and reduced risk of Alzheimer's disease[J], J Med Genet, 2008 ;45 (4) :244-8.
  • 3Paterson D,Nordberg A. Neuronal nicotinic receptors in the human brain [ J]. Prog Neurobiol,2000 ;61 ( 1 ) :75-111.
  • 4Elbashir SM, Lendeckel W, Tuschl T. RNA interference is mediated by 21 -and 22-nucleofide RNAs[ J]. Genes Dev,2001 ; 15 (2) : 188-200.
  • 5Brummelkamp TR, Bernards R, Agami R. A system for stable expression of short interfering RNAs in mammalian cells [J]. Science, 2002 ; 296( 5567 ) :550-3.
  • 6Paddison PJ, Candy AA, Bernstein E, et al. Short hairpin RNAs ( shRNAs) ineuce sequence-specific silencing in mammalian cells [J]. Genes Dev,2002 ;16(9) :948-58.
  • 7Guan ZZ, Miao H, Tian JY,et al. Suppressed expression of nicotinic acetylcholine receptors by nanomolar beta-amyloid peptides in PC12 cells [J]. J Neural Transm,2001 ;108(12) :1417-33.
  • 8Qi XL, Nordberg A, Xiu J,et al. The consequences of reducing expression of the α7 nicotinic receptor by RNA interference and of stimulating its activity with an α7 agonist in SH-SYSY cells indicate that this receptor plays a neuroprotective role in connection with the pathogenesis of Alzheimer's disease[J]. Neurochem Int,2007 ;51 (6-7) :377-83.
  • 9Cole SL, Vassar R. BACE1 structure and function in health and Alzheimer's disease[ J ]. Curr Alzheimer Res ,2008 ;5 (2) :100-20.
  • 10Fahrenholz F. Alpha-seeretase as a therapeutic target[ J]. Curr Alzheimet Res,2007 ;4(4) :412-7.

同被引文献13

  • 1肖雁,齐晓岚,吴昌学,张婷,赵艳,单可人,官志忠.洛伐他汀对PC12神经细胞中α7尼古丁受体的上调作用及其神经保护作用[J].中国老年学杂志,2007,27(10):924-926. 被引量:2
  • 2Nordberg A. Nicotinic receptor abnormalities of Alzheimer's disease: therapeutic implications[J]. Biol Psychiatry,2001 ;49 (3) : 200-10.
  • 3Doody RS,Stevens JC, Beck C. Practice parameter: management of dementia ( an evidence-based review) [J]. Neurology,2001 ;56(9) : 1154-66.
  • 4Paterson D, Nordberg A. Neuronal nicotinic receptors in the human brain [J].Prog Neurobiol,2000 ;61 ( 1 ) :75-111.
  • 5Hong L, Turner RT, Koelsch G, et al. Memapsin 2 ( beta-secretase ) as a therapeutic target[ J 1. Biochem Soc Trans,2002;30 (4) :530-4.
  • 6Kihara T, Shiohama S, Sawasa H, et al. Nicotinic receptor stimulation protects neurons against β-amyloid toxity [J]. Ann Neurol, 1997 ; 42 ( 2 ) : 159-63.
  • 7Guan ZZ, Miao H,Tian JY, et al.Suppressed expression of nicotinic acetylcholine receptors by nanomolar beta-amyloid peptides in PC12 cells [J]. J Neural Transm,2001 ;108(12) : 1417-33.
  • 8Vassar R, Bennett BD, Babu-Khan S, et al. Beta-secretase cleavage of Alzheimers amyloid precursor protein by the transmembrane aspartic protease BACE[J].Science, 1999 ;286 (5440) :735-41.
  • 9Vassar R, Citron M. Aβ-generating enzymes:recent advances in β- and γ- secretase research[J].Neuron,2000 ; 27 ( 3 ) :419 -22.
  • 10Anna M. Lilja,Omar Porras,Elisa Storelli,Agneta Nordberg,Amelia Marutle.Functional Interactions of Fibrillar and Oligomeric Amyloid-β with Alpha7 Nicotinic Receptors in Alzheimers Disease[J]. Journal of Alzheimers Disease . 2011 (2)

引证文献2

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部